Allogenic pooled olfactory mucosa-derived mesenchymal stem cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogenic pooled olfactory mucosa-derived mesenchymal stem cells, covering 2021-08-23 to 2021-08-23. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells [Phase 1, Phase 2]